ICON Selected by Shire plc’s Specialty Pharmaceuticals division as Global Strategic Partner for Clinical Research & Central...
09 Janeiro 2012 - 5:30AM
Business Wire
ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global
provider of outsourced development services to the pharmaceutical,
biotechnology and medical device industries, today announced that
is has signed a strategic partnership with Shire Specialty
Pharmaceuticals to serve as the sole global provider of central
laboratory services and one of two strategic partners for clinical
development services.
As a partner for clinical development, ICON will provide Shire
with a full range of services including site and country
feasibility, ethics and regulatory submissions, clinical trial
monitoring, project management, site and study team support,
medical management and medical data review. Shire will also utilise
ICON Central Laboratories’ extensive test menu from its global
network of laboratories.
“We are proud that Shire Specialty Pharmaceuticals has selected
ICON as a global partner and it is yet another endorsement of
ICON’s expertise in operating under strategic partnership models,”
commented Ciaran Murray, CEO, ICON plc. “ICON’s success is based on
the right blend of development services and global testing
facilities, all of which are underpinned by robust processes and
innovative technology. We look forward to building on our
successful relationship with Shire to help them realise
efficiencies as they seek to bring new products to market.”
About ICON plc
ICON plc is a global provider of outsourced development services
to the pharmaceutical, biotechnology and medical device industries.
The Company specialises in the strategic development, management
and analysis of programs that support clinical development - from
compound selection to Phase I-IV clinical studies. ICON currently
has around 8,500 employees, operating from 79 locations in 38
countries.
Further information is available at www.iconplc.com
Cautionary Note Regarding Forward-Looking
Statements
This release contains, and our officers and representatives may
from time to time make, "forward-looking statements" within the
meaning of the safe harbour provisions of the U.S. Private
Securities Litigation Reform Act of 1995. Forward-looking
statements can be identified by words such as: "anticipate,"
"intend," "plan," "expect," "strategy" and similar references to
future periods. Forward-looking statements are neither historical
facts nor assurances of future performance. Instead, they are based
only on our current beliefs, expectations and assumptions regarding
the future of our business, future plans and strategies,
anticipated events and trends, the economy and other future
conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties, risks and
changes in circumstances that are difficult to predict and many of
which are outside of our control. Our actual results may differ
materially from those indicated in the forward-looking statements.
Therefore, you should not rely on any of these forward-looking
statements. Important factors that could cause our actual results
to differ materially from those indicated in the forward-looking
statements include, among others, general economic and financial
conditions; the extent to which we are successful in implementing
our strategy, gaining new, long-term relationships with customers
and retaining existing ones; the risk of competition on us and on
our industry; developments and changes in laws and regulations; and
such other factors as discussed in Part I, Item 3 “Risk Factors” in
our Form 20-F for the fiscal year ended December 31, 2010. Any
forward-looking statement made by us in this release is based only
on information currently available to us and speaks only as of the
date on which it is made. We undertake no obligation to publicly
update any forward-looking statement, whether written or oral, that
may be made from time to time, whether as a result of new
information, future developments or otherwise.
ICON/ICLR-F
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024